Member Info for ConsDoms

Oh dear Charge.

not looking good for you is it? looking for someone to blame?

shame you cant meet them and tell them straight to their face

Interesting article Tight. thanks

HEMO CAR T is targeting AML rather than multiple myeloma.

But it just adds to the growing significance and potential benefit of engineering T cells.

IMHO

GLA

Im buying more Raymond BTW. Im comfortable with my research and the risk/ reward balance. If it goes belly up hard luck me. Do feel free to give an update from your tea leafs in the future though

Well done Raymond.

do you want a medal?

And hopefully a positive update on CBR...

Https://twitter.com/tmsreach/status/1664672451639246867?s=11&t=CwZpHUZhFOIY6BSujEHaLg

All the best Stu.

I haven't always agreed but Ive enjoyed your posts.

Nothing wrong with a well articulated counter view.

India

You (or I even) may have played a significant part in HH departure.

or are you too thick skinned to see...

Very funny Stu.

that really made me chuckle.

India and JH one and the same 😂

I guess you have earned your wind up...

India

you were pumping this heavily over the last few days - are you now distancing yourself from this ''merry band''?

''Comdoms ... I sent many emails to hemo and not a single response back yet when he needed the share price to rocket preplacing announcement, he put all those tweets and his merry band of pumpers pumped this to 4p. I am sorry that i ever invested and now many of us are confused on how long to stay and support the behaviour of this ceo !!!''

''Vlad has said many times he doesnt care about investors''

give just ONE example of when Vlad said that India

Very disappointing obviously.

hard to take on when previous RNS had indicated pre IND dialogue with FDA eg 16 Feb 2022:

''In the meantime, the process will be dealt with by written responses by the FDA to a submission which is now being refined. A pre-IND meeting will then be necessary only if the written responses leave any matters unresolved. In light of this written process now implemented by FDA, there is no anticipated impact from the deferment on the IND filing for HEMO-CAR-T''

the hope is of course this is just a minor technicality, aside from the fundamental science, that can readily be addressed.

I was confident this was more than a speculative punt (and I still am), but looking more like something for the bottom drawer to come back to in several months.

Stu articulated caution - fair enough.

Greatest shame of course is for those in desperate need of an alternative cancer treatment

9th May:

Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, announces the submission of an Investigational New Drug ("IND") application seeking authorization from the U.S. Food and Drug Administration ("FDA") to begin a Phase I clinical trial of its lead product candidate Chimeric Antigen Receptor ("CAR") T-cells ("HEMO-CAR-T") for treating acute myeloid leukemia (AML).

7th June will be 30 days.

Hopefully HEMO CAR T becoming clinical will shed a great light on HEMO and in particular CBR potential.

GLA

Many thanks Hulver

Who is ‘we’ Raymond? You might need him back.

No,

don’t remember him

Interesting Jamesslee.

Caribou Biosciences >300m mcap with CAR-T CB 010 + 011 at Phase 1.

- a relevant comparison I think it is fair to say.

thank you

Well said Simon.

sorry to see you go HH.

All the very best

I guess the dilemma for a few of us will be how much to slice , IF this starts moving North.

We dont know the ceiling this might reach if Phase 1 starts to show encouraging signs - £100m? (9p) or £250m? (22p). Who knows...

Then of course, in an ideal world, one would like to retain a significant holding to benefit from hopefully positive CBR developments over the coming months - that has to be worth a decent stake given the potential?

9th Jan RNS always worth a re read (Ok Pump you think it was pumped).

GLA

couldn’t be more wrong Whyme.
I think it is fair to say balanced posters expect folk to have done their own research and come to their own conclusions.
did you just follow posters on this board? oooops. oh dear